Changes in Hematologic Lab Measures Observed in Patients with Paroxysmal Nocturnal Hemoglobinuria Treated with C5 Inhibitors, Ravulizumab and Eculizumab: Real-World Evidence from a US Based EMR Network
Fishman, J., Kuranz, S., Yeh, M. M., Brzozowski, K., & Chen, H. (2023). Changes in Hematologic Lab Measures Observed in Patients with Paroxysmal Nocturnal Hemoglobinuria Treated with C5 Inhibitors, Ravulizumab and Eculizumab: Real-World Evidence from a US Based EMR Network. Hematology Reports, 15(2), 266-282. https://doi.org/10.3390/hematolrep15020027 View article Abstract Paroxysmal nocturnal hemoglobinuria (PNH), a rare acquired […]